Although smoking is regarded as the most important causal factor in chronic obstructive pulmonary disease (COPD), only 10–20% of smokers develop symptomatic COPD, which indicates the presence of genetic predisposing factors in its pathogenesis. This study investigates the association between gene polymorphysims of glutathione S-transferases (GSTs) and COPD. Blood samples were taken from 149 patients and 150 healthy controls. Polymorphisms of GSTT1, GSTM1, and GSTP1 were genotyped using Real-Time PCR. Multivariate logistic regression was used to calculate odds ratios (ORs) and 95% confidence intervals between specific genotypes and COPD. There was no difference in the frequencies of the genotypes of GSTM1 and GSTT1 between the groups, but the GSTP1 Ile/Ile genotype was significantly higher in the patients than in the controls (61.1% vs. 38%). GSTP1 Ile/Val and Val/Val genotypes were associated with a decreased risk of COPD when compared to the Ile/Ile genotype (2.12-fold and 4-fold, respectively). Thus we suggest that the Val allele of GSTP1 may have a protective effect for development of COPD. Furthermore, when we evaluated the association between GSTP1 genes and smoking status, smokers with the GSTP1 Ile allele had an increased risk for the development of COPD. Among the combinations of the genotypes, the combination of GSTM1, GSTT1 null, and GSTP1 Val/Val was associated with the maximal increased risk (12-fold) of COPD. Thus to explain the ethiopathogenesis of COPD, investigation of a single gene family is inadequate. Based on our results and the previous data, further studies should be focused on the GSTP1 gene and the interactions with other genes such as polymorphisms of N-acetyltransferases, GSTM1 and GSTT1, microsomal epoxide hydrolase, and allelic variants of cytochrome P450.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
Bascom, R. (1991). Differential suspectibility to tobacco smoke: Possible mechanisms. Pharmacogenetics 1:102–106.
Board, P. G., Webb, G. C., and Coggan, M. (1989). Isolation of a cDNA clone and localization of the human glutathione S-transferase 3 genes to chromosome bands 11q13 and 12q13-14. Ann. Hum. Genet. 53:205–213.
Cantlay, A. M., Smith, C. A., Wallace, W. A., Yap, P. L., Lamb, D., and Harrison, D. J. (1994). Heterogeneous expression and polymorphic genotype of glutathione S-transferases in human lung. Thorax 49:1010–1014.
Chen, H., Sandler, D. P., Taylor, J. A., Shore, D. L., Liu, E., Bloomfield, C. D., and Bell, D. A. (1996). Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta 1 gene defect. Lancet 347:295–297.
Chen, U., and Juchau, M. R. (1998). Inhibition of embryonic retinoic acid synthesis by aldehydes of lipid peroxidation and preventation of inhibition by reduced glutathione and glutathione S-transferases. Free Radic. Biol. Med. 24:408–417.
Cheng, S. L. (2004). Genetic polymorphism of epoxide hydrolase and glutathione S-transferase in COPD. Eur. Respir. J. 23:818–824.
Elexpuru-Camiruaga, J., Buxton, N., Kandula, V., Dias, P. S., Campbell, D., McIntosh, J., Broome, J., Jones, P., Inskip, A., and Alldersea, J. (1995). Suspectibilty to astrocytoma and meningioma: Influence of alleism at glutathione S-transferase (GSTT1, GSTM1) and cytochrome P-450 (CYP2D6) loci. Cancer Res. 55:4237–4239.
Fields, W. R., Morrow, C. S., Doss, A. J., Sundberg, K., Jernstrom, B., and Townsend, A. J. (1998). Overexpression of stably transfected human glutathione S-transferase P1-1 protects against DNA damage by benzo[a]pyrene diol-epoxide in human T47D cells. Mol. Pharmacol. 54:298–304.
Global Initiative for Chronic Obstructive Lung Disease (2003). Pocket Guide to COPD diagnosis, management, and prevention: A guide for physicians and nurses. Washington, D.C.: National Institutes of Health, NHLBI/WHO Workshop report.
Harrison, D. J., Cantlay, A. M., Rae, F., Lamb, D., and Smith, C. A. (1997). Frequency of glutathione S-transferase M1 deletion in smokers with emphysema and lung cancer. Hum. Exp. Toxicol. 17:356–360.
Helzlsouer, K. J., Selmin, O., Huang, H. Y., Strickland, P. T., Hoffman, S., Alberg, A. J., Watson, M., Comstock, G. W., and Bell, D. (1998). Association between glutathione S-transferase M1, T1, and P1 genetic polymorphisms and development of breast cancer. J. Natl. Cancer Inst. 90:512–518.
Hoffmann, D., and Hoffmann, I. (1997). The changing cigarette, 1950–1995. J. Toxicol. Environ. Health 50:307–364.
Ishii, T., Matsuse, T., Teramoto, S., Matsui, H., Miyao, M., Hosoi, T., Takahashi, H., Fukuchi, Y., and Ouchi, Y. (1999). Glutathione S-transferase P1 (GSTP1) polymorphism in patients with chronic obstructive pulmonary disease. Thorax 54:693–696.
Ishii, T., Matsuse, T., Teramoto, S., Matsui, H., Miyao, M., Hosoi, T., Takahashi, H., Fukuchi, Y., and Ouchi, Y. (2001). Tobacco smoke reduced viability in human lung fibroblasts: Protective effect of glutathione S-transferase P1. Am. J. Physiol. Lung Cell Mol. Physiol. 280:L1189–L1195.
Johansson, A. S. (2002). Exploring the functional plasticity of human glutathione transferases: Allelic variants, novel ısoenzyme and enzyme releasing. Acta universitatis upsaliensis (Comprehensive summaries of Uppsala dissertations from faculty of science and technology). Uppsala 695:56.
Johansson, A. S., and Mannervik, B. (2001). Interindividual variability of glutathione transferase expression. In Pacifici, G. M., and Pelkonen, O. (Eds.), Interindividual Variability in Human Drug Metabolism, Taylor & Francis, London, pp. 460–519.
Joos, L., Pare, P. D., and Sandford, A. J. (2002). Genetic risk factors for chronic obstructive pulmonary disease. Swiss Med. Weekly 132:27–37.
Ketterer, B. (1988). The protective role of glutathione and glutathione transferases in mutagenesis and carcinogenesis. Mutat. Res. 202:343–361.
Ko, Y., Koch, B., Harth, V., Sachinidis, A., Thier, R., Vetter, H., Bolt, H. M., and Bruning, T. (2000). Rapid analysis of GSTM1, GSTT1 and GSTP1 polymorphisms using Real-Time polymerase chain reaction. Pharmacogenetics 10:1–4.
Lu, B., and He, Q. (2002). Correlation between exon 5 polymorphism of glutathione S-transferase P1 gene and susceptibility to chronic obstructive pulmonary disease in northern Chinese population of Han nationality living in Beijing, China. Zhonghua Nei Ke Za Zhi 41:678–681.
Massaro, G. D., and Massaro, D. (1997). Retinoic acid treatment abrogates elastase-induced pulmonary emphysema. Nat. Med. 3:675–677.
Shanley, S. M., Chenevix-Trench, G., Palmer, J., and Hayward, N. (1995). Glutathione S-transferase M1 and T1 polymorphisms: Suspectibility to colon cancer and age of onset. Carcinogenesis 16:1655–1657.
Siafakas, N. M., Vermeire, P., Pride, N. B., Paoletti, P., Gibson, J., Howard, P., Yernault, J. C., Decramer, M., Higenbottam, T., and Postma, D. S. (1995). On behalf of the optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. Eur. Respir. J. 8:1398–1420.
Smith, C. A. D., and Harrison, D. J. (1997). Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema. Lancet 350:630–633.
Sundberg, K., Johansson, A. S., Stenberg, G., Widersten, M., Seidel, A., Mannervik, B., and Jernstrom, B. (1998). Differences in catalytic efficiencies of allelic variants of glutathione transferase P1-1 towards carcinogenic diol epoxide of polycyclic aromatic hydrocarbons. Carcinogenesis 433–436.
Tamer, L., Calikoglu, M., Ates, N. A., Yildirim, H., Ercan, B., Saritas, E., Unlu, A., and Atik, U. (2004). Glutathione-S-transferase gene polymorphisms (GSTT1, GSTM1, GSTP1) as increased risk factors for asthma. Respirology 9:493–498.
Watson, M. A., Stewart, R. K., Smith, G. B., Massey, T. E., and Bell, D. A. (1998). Human glutathione S-transferase P1 polymorphisms: Relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis 19:275–280.
Xiao, D., Wang, C., Du, M. J., Pang, B. S., Zhang, H. Y., Xiao, B., Liu, J. Z., Weng, X. Z., Su, L., and Christiani, D. C. (2004). Relationship between polymorphisms of genes encoding microsomal epoxide hydrolase and glutathione S-transferase P1 and chronic obstructive pulmonary disease. Chin. Med. J. 117:661–667.
Yim, J. J., Park, G. Y., Lee, C. T., Kim, Y. W., Han, S. K., Shim, Y. S., and Yoo, C. G. (2000). Genetic susceptibility to chronic obstructive pulmonary disease in Koreans: Combined analysis of polymorphic genotypes for microsomal epoxide hydrolase and glutathione S-transferase M1 and T1. Thorax 55:121–125.
Yim, J. J., Yoo, C. G., Lee, C. T., Kim, Y. W., Han, S. K., and Shim, Y. S. (2002). Lack of association between glutathione S-transferase P1 poymorphism and COPD in Koreans. Lung 180:119–125.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Çalıkoglu, M., Tamer, L., Ates Aras, N. et al. The Association Between Polymorphic Genotypes of Glutathione S-Transferases and COPD in the Turkish Population. Biochem Genet 44, 307–319 (2006). https://doi.org/10.1007/s10528-006-9031-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10528-006-9031-4